Endoluminal LIGHT Activated Treatment

· Steba Biotech S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Endoluminal LIGHT Activated Treatment, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study [Phase 3]